ANGPTL3, a protein primarily expressed in the liver, is commonly targeted by inhibitors as an effective strategy for treating hypertriglyceridemia and other lipid metabolism disorders [56]. This evidence concerns the gene ANGPTL3 and Disorder of lipid metabolism.